Rx-to-OTC Switch Interest Explodes Following Deal Activity - Experts
This article was originally published in The Tan Sheet
Pharmaceutical firms are developing and reshaping their Rx-to-OTC switch strategies to remain competitive in an evolving industry where recent mergers and acquisitions underscore the importance of an OTC presence and switch platform
You may also be interested in...
Quality control problems for Johnson & Johnson's McNeil Consumer Healthcare business and the regulatory and congressional scrutiny that followed dominated the attention of drug and dietary supplement industry stakeholders in 2010.
Meda Pharmaceuticals acquires a larger U.S. presence with an eye on OTC growth, including potential switch candidates
Switching statins OTC will require comprehensive consumer education to enable self-selection and flexibility from FDA on the types of information it considers product labeling